A notable advancement in blood sugar management is emerging with the approval of tirzepatide in a 45mg form. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://loanbookmark.com/story21404739/groundbreaking-introduction-tirzepatide-45mg-for-diabetes-regulation